Stifel reiterates Buy on Essential Properties stock, $36 target
Source: Investing.com

Stifel reiterated its Buy rating and $36 price target on Essential Properties Realty Trust, implying roughly 33% upside from the $27.05 share price, despite the stock declining 7.9% year-to-date. The firm expects EPRT to deliver 6.9% AFFO CAGR in 2025-2028 versus 4.1% for net-lease peers, supported by an investment pipeline exceeding $800 million, favorable acquisition spreads and $1.7 billion of liquidity. EPRT also beat Q2 expectations with $0.34 EPS and $161.89 million of revenue, raised full-year guidance, and expanded its revolver to $1.3 billion.
Analysis
EPRT’s discount to larger net-lease peers is unlikely to close solely on another analyst target increase; the re-rating mechanism is proof that external growth remains accretive after incorporating its true marginal cost of equity. The forward-equity capacity that supports acquisitions also creates a near-term dilution overhang, so the stock can lag until closed investments begin contributing to AFFO. Relative beneficiaries of a sustained lower-rate environment would likely be EPRT and ADC versus mature, lower-growth O and NNN, where valuation support is more yield-driven than acquisition-spread driven.
The key 1-3 month catalyst is evidence that committed acquisitions close at stated economics without a deterioration in tenant credit quality or cap rates. A lower revolver pricing grid marginally improves acquisition economics, but it does not eliminate the risk that equity issuance, higher long-end Treasury yields, or wider REIT credit spreads erase the incremental spread. The article’s mixed and apparently auto-generated framing reduces confidence in the precision of the reported forward estimates; investors should underwrite management’s pipeline only after the next supplemental discloses funding mix, tenant concentration, and actual versus guided initial cash yields.
Contrarian view: the underperformance may reflect a rational market discount for small-cap liquidity and external-growth dependence rather than a temporary valuation anomaly. If the 10-year Treasury remains elevated or rises, EPRT can deliver operating growth while its AFFO multiple still contracts; that is the central asymmetry versus a simple ‘undervalued REIT’ thesis. Over 6-18 months, the structural upside exists only if acquisition volume converts into per-share AFFO growth faster than share count growth.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.48
Ticker Sentiment
Key Decisions for Investors
- Initiate a starter long EPRT only on a hold above the recent low area near $26.47, sized as a 1-3 month catalyst trade; use a weekly close below that level as thesis invalidation. Upside requires confirmation of accretive deployment, not analyst-rating momentum.
- Express the relative-growth thesis as long EPRT / short NNN or O in equal dollar amounts over 3-6 months, rather than an outright REIT-beta long. Exit if EPRT’s reported per-share AFFO growth fails to exceed the peer set or if the acquisition funding mix becomes materially equity-heavy.
- Do not add ahead of the next earnings release without verifying three data points: closed versus announced investment volume, initial cash yield on closings, and forward-equity settlement timing. A shortfall in any of these would indicate that pipeline visibility is not translating into per-share economics.
- Maintain a rate hedge against any outright EPRT exposure through a modest short IYR or long-duration Treasury hedge until the long end stabilizes; a renewed rise in 10-year yields or REIT credit spreads is more likely to drive the stock near term than incremental operating beats.
More News
- Microsoft will get a boost from Azure and Copilot, Stifel says
- Meta is breaking out after introducing Muse AI agent. Where the stock is going, according to the charts
- The SaaS debt trap
- Citizens cuts Compass Therapeutics stock price target on FDA trial request
- UBS initiates Applied Digital stock with buy rating on AI data center growth
- Bernstein initiates TE Connectivity stock coverage with outperform rating